9
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Environmental chemistry is most relevant to study coronavirus pandemics

      editorial

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          On May 18, 2020, the COVID-19 pandemic has globally killed 315,248 people since the virus outbreak in Wuhan, China, in early December 2019 (https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6). As a matter of urgency, research has promptly focused on designing cures and vaccines, which is understandable, but is the classical ‘painkiller’ approach that will be less and less efficient in our globalized society because such an approach is treating the effect and not the original cause (Lichtfouse 2009, 2010). In particular, this is somehow underestimating environmental factors such as climate change and pollution that have more or less directly favored the pandemic. For instance, climate modeling has predicted increased risks of food- and water-borne diseases with very high confidence (Woodward et al. 2014). Similarly, air pollution has been shown to alter the immune system (Glencross et al. 2020; Bauer et al. 2012). Environmental chemistry, as the science of contaminants in the environment, thus deserves more attention to prevent future pandemics (Qu et al. 2020). The emergence of viral epidemics in the past 20 years has caused great threats to public health (Wang et al. 2020). Lassa and Ebola are examples of infectious viruses associated with hemorrhagic fever. The novel coronavirus is a class of enveloped, positive-sense single-stranded RNA viruses that are responsible for the Middle East respiratory syndrome, MERS-CoV, and the severe acute respiratory syndrome, SARS-CoV, in humans. The current pandemic caused by the novel coronavirus SARS-CoV-2 causes severe acute respiratory symptoms and is often referred to as coronavirus infectious diseases 2019: COVID-19. No effective vaccine or drugs are available, which makes it very challenging to treat or prevent the deadly COVID-19. Below are some of our thoughts on how environmental chemists can play pivotal role in understanding the occurrence and evolution of COVID-19 in protection of the global community. In the environment, SARS-CoV-2 may survive in the air, on the surfaces, in water and wastewater (Qu et al. 2020). In the air, the SARS-CoV-2 virus may be present as droplets, or as dust, or particulate matter (PM). The decay of the virus under various environmental conditions would determine the survival of the virus. These conditions may include the size of particulate matter and aerosols, humidity and temperature. These suggest the potential role of climate change on occurrence and the fate of the virus. Environmental chemistry research on the fate of pollutants in air (Kfoury et al. 2016; Yu 2019; Gopinath and Kadirvelu 2018), water (Gopinath and Kadirvelu 2018; Mahmood et al. 2012; Rodgers et al. 2019; Wen et al. 2019) and wastewater (Padervand et al. 2020; Simas et al. 2019; Villaseñor and Ríos 2018; Crini and Lichtfouse 2019) is therefore highly relevant to the study of pathogenic microbes. Future detailed investigations about the physiochemical role of environmental parameters of air might therefore address the control of future outbreaks or pandemics with greater efficiency. The survival of SARS-CoV-2 on solid surfaces might be of high importance. For example, the novel coronavirus may survive for prolonged periods on surfaces such as latex gloves, sterile sponges, aluminum, wood, laminate, steel and plastics. Viruses usually have longer survival in a host and thus may have increased likelihood of transmission. Similarly, complete information is essential on how the novel coronavirus interacts with surfaces on a mask that vary in composition, material  and pore size to understand survival and protection. Systematically designed experiments will help us gain insight into the virus survival on various surfaces, thus minimizing the exposure of the novel coronavirus to the humans. Here, recent research in environmental chemistry has shown the role of surface materials on antimicrobial resistance (Khan et al. 2019) and bacterial communities (Dong et al. 2019). Surprisingly, researchers are paying little attention on the interaction of the virus with food products such as vegetable and fruits, whereas food-borne outbreaks such as diarrheal outbreaks due to the contamination of food by Escherichia coli in spinach are well described (Sharapov et al. 2016). Fundamental understanding of the survival and possible replication of SARS-CoV-2 on different food will improve food security and safety of the global community. Additional insights might be gained from recent reports on smart packaging (Rai et al. 2019; Gaikwad et al. 2019; Pandit et al. 2017), biosensors (Brinda et al. 2018; Jyoti and Tomar 2017) and nanotechnology (Manickam et al. 2017; Dasgupta et al. 2019) (Fig. 1). Fig. 1 Environmental research findings on nanoparticles could be useful to study the behavior of viruses. Modified after Manickam et al. (2017) Generally, viruses in water come from excretion in feces. Viruses can survive in fecal matter and in sewage water for up to 10 days. Very little information is currently available on the transmission of enveloped viruses via feco-oral transmission or through our sewer system. In case of the 2003 SARS outbreak, the human coronavirus was found in stool samples (Peiris et al. 2003). The urine samples have also shown human enveloped viruses such as the cytomegalovirus (CMV). The first detection of SARS-CoV-2 in sewage occurred on March 5, 2020 in the sewage systems of the Schiphol airoport and major cities in the Netherlands, only one week into the epidemic (Medema et al. 2020). Coronavirus-type viruses may inactivate in wastewater, with temperature highly influencing the inactivation rate (Wigginton and Boehm 2020). During wastewater treatment, oxidants and disinfectants can inactivate enveloped viruses (Manoli et al. 2020). However, many poor communities lack the infrastructure to provide clean water, and therefore would face exposure of infectious viruses. Additionally, faulty plumbing in buildings may increase exposure to the viruses. Very limited data sets are available on human viruses in the literature. Research on enveloped-virus transmission and on the treatment of wastewater must include a wide range of enveloped viruses. Here, environmental chemists have developed a wide array of wastewater treatment techniques (Crini and Lichtfouse 2019; Bello and Raman 2019; Crini et al. 2019; Lichtfouse et al. 2019; Bouabidi et al. 2019; Bourgeois et al. 2015), which deserve further testing for virus inactivation. In determining the fate of novel coronavirus, measurements should be conducted with great care regarding conditions and characterizing the media composition. The purity of the stock of virus must be checked fully. Many efforts should be made to explain the novel coronavirus concentrations in gene copies and infected units. The recommendation of using oxidants and disinfectants to inactivate SARS-CoV-2 must be experimentally based, which includes testing dose demand and contact time under the environmental conditions at which the virus would be presented. In applying light-based processes to inactivate the SARS-CoV-2, attenuation through the treated water must be fully reported. Researchers should also study the surrogate virus, similarly as the well-investigated nonenveloped bacteriophage MS2, thus enabling different laboratories in world to compare their findings among different global communities. Overall, research in environmental chemistry is disclosing unique knowledge that may help to understand the behavior of viruses and other microbial pathogens in the environment. Therefore, we advise that environmental chemists and biomedical scientists collaborate to decipher mechanisms and design adapted treatments to fight pandemics.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          A novel coronavirus outbreak of global health concern

          In December, 2019, Wuhan, Hubei province, China, became the centre of an outbreak of pneumonia of unknown cause, which raised intense attention not only within China but internationally. Chinese health authorities did an immediate investigation to characterise and control the disease, including isolation of people suspected to have the disease, close monitoring of contacts, epidemiological and clinical data collection from patients, and development of diagnostic and treatment procedures. By Jan 7, 2020, Chinese scientists had isolated a novel coronavirus (CoV) from patients in Wuhan. The genetic sequence of the 2019 novel coronavirus (2019-nCoV) enabled the rapid development of point-of-care real-time RT-PCR diagnostic tests specific for 2019-nCoV (based on full genome sequence data on the Global Initiative on Sharing All Influenza Data [GISAID] platform). Cases of 2019-nCoV are no longer limited to Wuhan. Nine exported cases of 2019-nCoV infection have been reported in Thailand, Japan, Korea, the USA, Vietnam, and Singapore to date, and further dissemination through air travel is likely.1, 2, 3, 4, 5 As of Jan 23, 2020, confirmed cases were consecutively reported in 32 provinces, municipalities, and special administrative regions in China, including Hong Kong, Macau, and Taiwan. 3 These cases detected outside Wuhan, together with the detection of infection in at least one household cluster—reported by Jasper Fuk-Woo Chan and colleagues 6 in The Lancet—and the recently documented infections in health-care workers caring for patients with 2019-nCoV indicate human-to-human transmission and thus the risk of much wider spread of the disease. As of Jan 23, 2020, a total of 835 cases with laboratory-confirmed 2019-nCoV infection have been detected in China, of whom 25 have died and 93% remain in hospital (figure ). 3 Figure Timeline of early stages of 2019-nCoV outbreak 2019-nCoV=2019 novel coronavirus. In The Lancet, Chaolin Huang and colleagues 7 report clinical features of the first 41 patients admitted to the designated hospital in Wuhan who were confirmed to be infected with 2019-nCoV by Jan 2, 2020. The study findings provide first-hand data about severity of the emerging 2019-nCoV infection. Symptoms resulting from 2019-nCoV infection at the prodromal phase, including fever, dry cough, and malaise, are non-specific. Unlike human coronavirus infections, upper respiratory symptoms are notably infrequent. Intestinal presentations observed with SARS also appear to be uncommon, although two of six cases reported by Chan and colleagues had diarrhoea. 6 Common laboratory findings on admission to hospital include lymphopenia and bilateral ground-glass opacity or consolidation in chest CT scans. These clinical presentations confounded early detection of infected cases, especially against a background of ongoing influenza and circulation of other respiratory viruses. Exposure history to the Huanan Seafood Wholesale market served as an important clue at the early stage, yet its value has decreased as more secondary and tertiary cases have appeared. Of the 41 patients in this cohort, 22 (55%) developed severe dyspnoea and 13 (32%) required admission to an intensive care unit, and six died. 7 Hence, the case-fatality proportion in this cohort is approximately 14·6%, and the overall case fatality proportion appears to be closer to 3% (table ). However, both of these estimates should be treated with great caution because not all patients have concluded their illness (ie, recovered or died) and the true number of infections and full disease spectrum are unknown. Importantly, in emerging viral infection outbreaks the case-fatality ratio is often overestimated in the early stages because case detection is highly biased towards the more severe cases. As further data on the spectrum of mild or asymptomatic infection becomes available, one case of which was documented by Chan and colleagues, 6 the case-fatality ratio is likely to decrease. Nevertheless, the 1918 influenza pandemic is estimated to have had a case-fatality ratio of less than 5% 13 but had an enormous impact due to widespread transmission, so there is no room for complacency. Table Characteristics of patients who have been infected with 2019-nCoV, MERS-CoV, and SARS-CoV7, 8, 10, 11, 12 2019-nCoV * MERS-CoV SARS-CoV Demographic Date December, 2019 June, 2012 November, 2002 Location of first detection Wuhan, China Jeddah, Saudi Arabia Guangdong, China Age, years (range) 49 (21–76) 56 (14–94) 39·9 (1–91) Male:female sex ratio 2·7:1 3·3:1 1:1·25 Confirmed cases 835† 2494 8096 Mortality 25† (2·9%) 858 (37%) 744 (10%) Health-care workers 16‡ 9·8% 23·1% Symptoms Fever 40 (98%) 98% 99–100% Dry cough 31 (76%) 47% 29–75% Dyspnoea 22 (55%) 72% 40–42% Diarrhoea 1 (3%) 26% 20–25% Sore throat 0 21% 13–25% Ventilatory support 9·8% 80% 14–20% Data are n, age (range), or n (%) unless otherwise stated. 2019-nCoV=2019 novel coronavirus. MERS-CoV=Middle East respiratory syndrome coronavirus. SARS-CoV=severe acute respiratory syndrome coronavirus. * Demographics and symptoms for 2019-nCoV infection are based on data from the first 41 patients reported by Chaolin Huang and colleagues (admitted before Jan 2, 2020). 8 Case numbers and mortalities are updated up to Jan 21, 2020) as disclosed by the Chinese Health Commission. † Data as of Jan 23, 2020. ‡ Data as of Jan 21, 2020. 9 As an RNA virus, 2019-nCoV still has the inherent feature of a high mutation rate, although like other coronaviruses the mutation rate might be somewhat lower than other RNA viruses because of its genome-encoded exonuclease. This aspect provides the possibility for this newly introduced zoonotic viral pathogen to adapt to become more efficiently transmitted from person to person and possibly become more virulent. Two previous coronavirus outbreaks had been reported in the 21st century. The clinical features of 2019-nCoV, in comparison with SARS-CoV and Middle East respiratory syndrome (MERS)-CoV, are summarised in the table. The ongoing 2019-nCoV outbreak has undoubtedly caused the memories of the SARS-CoV outbreak starting 17 years ago to resurface in many people. In November, 2002, clusters of pneumonia of unknown cause were reported in Guangdong province, China, now known as the SARS-CoV outbreak. The number of cases of SARS increased substantially in the next year in China and later spread globally, 14 infecting at least 8096 people and causing 774 deaths. 12 The international spread of SARS-CoV in 2003 was attributed to its strong transmission ability under specific circumstances and the insufficient preparedness and implementation of infection control practices. Chinese public health and scientific capabilities have been greatly transformed since 2003. An efficient system is ready for monitoring and responding to infectious disease outbreaks and the 2019-nCoV pneumonia has been quickly added to the Notifiable Communicable Disease List and given the highest priority by Chinese health authorities. The increasing number of cases and widening geographical spread of the disease raise grave concerns about the future trajectory of the outbreak, especially with the Chinese Lunar New Year quickly approaching. Under normal circumstances, an estimated 3 billion trips would be made in the Spring Festival travel rush this year, with 15 million trips happening in Wuhan. The virus might further spread to other places during this festival period and cause epidemics, especially if it has acquired the ability to efficiently transmit from person to person. Consequently, the 2019-nCoV outbreak has led to implementation of extraordinary public health measures to reduce further spread of the virus within China and elsewhere. Although WHO has not recommended any international travelling restrictions so far, 15 the local government in Wuhan announced on Jan 23, 2020, the suspension of public transportation, with closure of airports, railway stations, and highways in the city, to prevent further disease transmission. 16 Further efforts in travel restriction might follow. Active surveillance for new cases and close monitoring of their contacts are being implemented. To improve detection efficiency, front-line clinics, apart from local centres for disease control and prevention, should be armed with validated point-of-care diagnostic kits. Rapid information disclosure is a top priority for disease control and prevention. A daily press release system has been established in China to ensure effective and efficient disclosure of epidemic information. Education campaigns should be launched to promote precautions for travellers, including frequent hand-washing, cough etiquette, and use of personal protection equipment (eg, masks) when visiting public places. Also, the general public should be motivated to report fever and other risk factors for coronavirus infection, including travel history to affected area and close contacts with confirmed or suspected cases. Considering that substantial numbers of patients with SARS and MERS were infected in health-care settings, precautions need to be taken to prevent nosocomial spread of the virus. Unfortunately, 16 health-care workers, some of whom were working in the same ward, have been confirmed to be infected with 2019-nCoV to date, although the routes of transmission and the possible role of so-called super-spreaders remain to be clarified. 9 Epidemiological studies need to be done to assess risk factors for infection in health-care personnel and quantify potential subclinical or asymptomatic infections. Notably, the transmission of SARS-CoV was eventually halted by public health measures including elimination of nosocomial infections. We need to be wary of the current outbreak turning into a sustained epidemic or even a pandemic. The availability of the virus' genetic sequence and initial data on the epidemiology and clinical consequences of the 2019-nCoV infections are only the first steps to understanding the threat posed by this pathogen. Many important questions remain unanswered, including its origin, extent, and duration of transmission in humans, ability to infect other animal hosts, and the spectrum and pathogenesis of human infections. Characterising viral isolates from successive generations of human infections will be key to updating diagnostics and assessing viral evolution. Beyond supportive care, 17 no specific coronavirus antivirals or vaccines of proven efficacy in humans exist, although clinical trials of both are ongoing for MERS-CoV and one controlled trial of ritonavir-boosted lopinavir monotherapy has been launched for 2019-nCoV (ChiCTR2000029308). Future animal model and clinical studies should focus on assessing the effectiveness and safety of promising antiviral drugs, monoclonal and polyclonal neutralising antibody products, and therapeutics directed against immunopathologic host responses. We have to be aware of the challenge and concerns brought by 2019-nCoV to our community. Every effort should be given to understand and control the disease, and the time to act is now. This online publication has been corrected. The corrected version first appeared at thelancet.com on January 29, 2020
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Advantages and disadvantages of techniques used for wastewater treatment

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Conventional and non-conventional adsorbents for wastewater treatment

                Bookmark

                Author and article information

                Contributors
                vsharma@tamu.edu
                chetan.jinadatha@va.gov
                eric.lichtfouse@gmail.com
                Journal
                Environ Chem Lett
                Environ Chem Lett
                Environmental Chemistry Letters
                Springer International Publishing (Cham )
                1610-3653
                1610-3661
                20 May 2020
                : 1-4
                Affiliations
                [1 ]GRID grid.264756.4, ISNI 0000 0004 4687 2082, Department of Environmental and Occupational Health, School of Public Health, , Texas A&M University, ; College Station, TX 77843 USA
                [2 ]GRID grid.413775.3, ISNI 0000 0004 0420 5847, Central Texas Veterans Health Care System, ; 1901 Veterans Memorial Drive, Temple, TX USA
                [3 ]GRID grid.5399.6, ISNI 0000 0001 2176 4817, CNRS, IRD, INRAE, Coll France, CEREGE, , Aix-Marseille Univ, ; 13100 Aix-en-Provence, France
                Author information
                http://orcid.org/0000-0002-8535-8073
                Article
                1017
                10.1007/s10311-020-01017-6
                7237241
                32837480
                bf404cd4-af78-4b32-9828-256db966352d
                © Springer Nature Switzerland AG 2020

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                Categories
                Editorial

                Environmental chemistry
                Environmental chemistry

                Comments

                Comment on this article